Status:
COMPLETED
Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan
Lead Sponsor:
Ono Pharma USA Inc
Conditions:
Postoperative Supraventricular Tachyarrythmia
Eligibility:
All Genders
21-79 years
Phase:
PHASE2
Brief Summary
The purpose of this study was to evaluate the dose-dependent effects of ONO-1101 on efficacy and safety in patients with postoperative supraventricular tachyarrhythmias.
Eligibility Criteria
Inclusion
- 20-80 years old
- Postoperative supraventricular tachyarrhythmias (sinus tachycardia, those with a heart rate of 120 beats/min or higher, and supraventricular arrhythmia, those with a heart rate of 100 beats/min or higher)
- Within 7 days postoperatively
- Other inclusion criteria as specified in the protocol
Exclusion
- Acute myocardial infarction (within 1 month after onset)
- Severe heart failure (New York Heart Association functional class III or higher)
- Atrioventricular block (grade II or higher),or sick sinus syndrome
- Other exclusion criteria as specified in the protocol
Key Trial Info
Start Date :
December 1 1996
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00212680
Start Date
December 1 1996
Last Update
October 11 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.